Briefing
Distinct longitudinal patterns of urine tumor DNA in patients undergoing surveillance for bladder cancer.
Detected 21/23 recurrences (91%): 5/5 T1, T2, and CIS (100%) and 10/12 Ta (83%); <1% false-negative tests.
- n: 47 patients, 2-year surveillance